Rebetol (ribavirin; SCH 18908)
Sponsors
Merck Sharp & Dohme LLC
Conditions
FibrosisHepatitisHepatitis CHepatitis C, ChronicLiver CirrhosisSubstance Abuse, Intravenous
Phase 3
PEG-Intron Plus Rebetol Treatment of Chronic Hepatitis C Subjects Who Failed Response to Alpha-Interferon Plus Ribavirin (Study P02370)
CompletedNCT00039871
Start: 2002-05-31End: 2007-09-30Updated: 2017-04-04
Peginterferon Dose Evaluations for Previously Untreated Subjects With Chronic Hepatitis C Infected With Genotype 1 (Study P03471)
CompletedNCT00081770
Start: 2004-03-31End: 2007-11-30Updated: 2017-04-04
Inhibition of Disease Progression in Hepatitis C-infected Patients With Compensated Liver Cirrhosis (P03811) (COMPLETED)
TerminatedNCT00811967
Start: 2003-02-28End: 2006-05-31Updated: 2017-03-13
Unknown Phase
An Observational Study of Patients With Chronic Hepatitis C Undergoing Treatment With PegIntron and Rebetol in Clinical Practice in Belgium (Study P05494)(WITHDRAWN)
WithdrawnNCT00704756
Start: 2009-01-31End: 2010-03-31Updated: 2014-08-11
Evaluation of Patient Satisfaction in Hepatitis C Patients Treated With PegIntron Pen and Rebetol in Romania (Study P04301)
CompletedNCT00704717
Start: 2005-09-30End: 2007-12-31Updated: 2015-04-29
Adherence to Treatment With PegIntron Pen Plus Rebetol in Treatment-naïve Adult Patients With Hepatitis C in Romania (Study P04247)
TerminatedNCT00705107
Start: 2004-11-30End: 2007-11-30Updated: 2015-06-30
Efficacy of PegIntron and Rebetol in Previously Untreated Patients With Chronic Hepatitis C Infected With HCV Genotype 1/4/5/6 (Study P04243)
CompletedNCT00709059
Start: 2004-12-31End: 2009-12-31Updated: 2015-11-04
Safety and Efficacy of PegIntron Plus Rebetol in Patients With Chronic Hepatitis C in Japan, Excluding (1) Subjects With HCV Genotype 1 and High Viral Load, and (2) Interferon-naïve Subjects With Low Viral Load (Study P04841)(COMPLETED)
CompletedNCT00724230
Start: 2006-02-28End: 2008-12-31Updated: 2015-02-03
Evaluation of Rapid Virologic Response Among HCV Patients Treated With PegIntron and Rebetol in Brazil (Study P05427)
CompletedNCT00724854
Start: 2006-08-31End: 2009-09-30Updated: 2015-02-25
Real-life Surveillance Study of Patients With Chronic Hepatitis C Treated With PegIntron Injector and Rebetol (Study P04538)(COMPLETED)
CompletedNCT00727311
Start: 2005-08-31End: 2009-06-30Updated: 2015-10-09
Post-marketing Surveillance of Children With Chronic Hepatitis C Treated With Intron A (Vial or Pen) and Rebetol (Study P04397)(TERMINATED)
TerminatedNCT00727077
Start: 2006-06-30End: 2007-06-30Updated: 2015-04-08
Post-marketing Surveillance Study of Ex-intravenous Drug Abusers With Chronic Hepatitis C Treated With PegIntron Plus Rebetol (P04408/MK-4031-261)
CompletedNCT00726557
Start: 2005-10-31End: 2009-01-31Updated: 2015-10-09
Compliance of HCV Genotype 1 Infected Patients Receiving PegIntron/Rebetol and a Patient Assistance Program (Study P04671)
CompletedNCT00728494
Start: 2005-10-31End: 2007-12-31Updated: 2015-07-28